With the new year, we are excited to continue our work on antenatal corticosteroid use to improve neonatal outcomes. Recently we submitted the protocol for a study “Maternal and neonatal outcomes of lower vs. standard doses of antenatal corticosteroids for women at risk of preterm birth; A systematic review and meta-analysis of randomized controlled trials” to Prospero for registration on December 10, 2019.